Merck & Company Inc (MRK.DE)
Company Info
Highlights
€58.83B
€6.19
21.86
1.58
€15.74B
€9.39B
€4.65B
€133.35 - €177.00
€182.63
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in Merck & Company Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Merck & Company Inc had a return of -3.86% year-to-date (YTD) and -9.83% in the last 12 months. Over the past 10 years, Merck & Company Inc had an annualized return of 5.76%, while the S&P 500 had an annualized return of 11.21%, indicating that Merck & Company Inc did not perform as well as the benchmark.
MRK.DE
-3.86%
-4.37%
-19.58%
-9.83%
3.39%
5.76%
^GSPC (Benchmark)
2.90%
3.70%
10.94%
22.18%
12.41%
11.21%
Monthly Returns
The table below presents the monthly returns of MRK.DE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 4.65% | -3.86% | |||||||||||
| 2024 | 5.76% | 3.54% | 3.68% | -7.62% | 11.78% | -7.06% | 7.14% | 6.06% | -10.15% | -3.80% | -6.84% | -1.20% | -1.49% |
| 2023 | 5.61% | -6.12% | -4.35% | -5.25% | 1.52% | -6.88% | 5.44% | 3.88% | -4.73% | -9.99% | 12.50% | -10.02% | -19.23% |
| 2022 | -14.58% | -8.43% | 6.93% | -5.81% | -1.10% | -8.00% | 15.34% | -7.70% | -2.68% | -1.08% | 5.33% | 4.09% | -19.46% |
| 2021 | -1.89% | -2.29% | 8.36% | 1.23% | 0.96% | 9.59% | 6.77% | 16.54% | -6.73% | 8.82% | 7.20% | 3.70% | 63.33% |
| 2020 | 10.01% | -5.91% | -14.15% | 14.76% | -1.57% | 0.15% | 4.60% | 5.18% | 9.59% | 2.09% | 5.27% | 4.86% | 36.58% |
| 2019 | 1.78% | -0.87% | 11.97% | -5.42% | -8.87% | 6.36% | 0.52% | 5.21% | 6.26% | 3.43% | -0.84% | -0.61% | 18.63% |
| 2018 | -1.93% | -6.59% | -5.25% | 5.86% | 7.54% | -4.26% | 5.09% | 2.96% | -1.64% | 6.31% | 2.90% | -7.58% | 1.79% |
| 2017 | 2.52% | 1.48% | 3.54% | 0.94% | 0.79% | -1.58% | -12.20% | -0.64% | 2.02% | -2.37% | -2.68% | 0.36% | -8.46% |
| 2016 | -10.60% | -2.09% | -6.50% | 11.95% | 11.02% | 1.22% | 8.47% | -4.48% | 1.66% | -2.35% | 0.94% | 4.88% | 12.13% |
| 2015 | 13.12% | 3.93% | 13.39% | -6.53% | 0.60% | -8.21% | 3.62% | -7.94% | -7.25% | 12.32% | 9.13% | -7.60% | 15.32% |
| 2014 | -11.59% | 10.29% | -3.74% | -0.57% | 5.29% | 0.62% | 4.72% | -0.23% | 10.27% | -1.31% | 11.11% | -2.07% | 22.31% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of MRK.DE is 23, meaning it’s performing worse than 77% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Merck & Company Inc (MRK.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Merck & Company Inc provided a 1.64% dividend yield over the last twelve months, with an annual payout of €2.20 per share. The company has been increasing its dividends for 3 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | €2.20 | €2.20 | €2.20 | €1.85 | €1.40 | €2.60 | €1.25 | €1.25 | €1.20 | €1.05 | €1.00 | €0.95 |
Dividend yield | 1.64% | 1.57% | 1.53% | 1.02% | 0.62% | 1.85% | 1.19% | 1.39% | 1.34% | 1.06% | 1.12% | 1.21% |
Monthly Dividends
The table displays the monthly dividend distributions for Merck & Company Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | €0.00 | €0.00 | €0.00 | ||||||||||
| 2024 | €0.00 | €0.00 | €0.00 | €2.20 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.20 |
| 2023 | €0.00 | €0.00 | €0.00 | €0.00 | €2.20 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.20 |
| 2022 | €0.00 | €0.00 | €0.00 | €1.85 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.85 |
| 2021 | €0.00 | €0.00 | €0.00 | €1.40 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.40 |
| 2020 | €0.00 | €0.00 | €0.00 | €1.30 | €1.30 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.60 |
| 2019 | €0.00 | €0.00 | €0.00 | €1.25 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.25 |
| 2018 | €0.00 | €0.00 | €0.00 | €1.25 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.25 |
| 2017 | €0.00 | €0.00 | €0.00 | €0.00 | €1.20 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.20 |
| 2016 | €0.00 | €0.00 | €0.00 | €0.00 | €1.05 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.05 |
| 2015 | €0.00 | €0.00 | €0.00 | €1.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.00 |
| 2014 | €0.95 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.95 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Merck & Company Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Merck & Company Inc was 62.49%, occurring on Oct 1, 2002. Recovery took 391 trading sessions.
The current Merck & Company Inc drawdown is 39.03%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -62.49% | Nov 15, 2000 | 476 | Oct 1, 2002 | 391 | Apr 21, 2004 | 867 |
| -45.48% | Jun 18, 2007 | 437 | Mar 6, 2009 | 915 | Oct 1, 2012 | 1352 |
| -39.49% | Dec 29, 2021 | 504 | Dec 13, 2023 | — | — | — |
| -37.92% | Jul 23, 1998 | 403 | Feb 22, 2000 | 156 | Oct 2, 2000 | 559 |
| -35.3% | Feb 20, 2020 | 20 | Mar 18, 2020 | 124 | Sep 14, 2020 | 144 |
Volatility
Volatility Chart
The current Merck & Company Inc volatility is 7.64%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Merck & Company Inc compared to its peers in the Drug Manufacturers - Specialty & Generic industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for MRK.DE in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, MRK.DE has a PE value of 21.9. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for MRK.DE in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, MRK.DE has a PEG value of 1.6. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Merck & Company Inc.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |